Contracts Finder notice
NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)
This award is linked to an earlier notice for the same procurement. The two notices count as one procedure. View the earlier notice.
Authority: NHS England
CPV: Pharmaceutical products (33600000)
Published framework value£608,000,000Agreement value, exc. VAT; may be a ceiling, not a single purchase
Contract ends 31 Mar 2028
Panel 6 suppliersBaxter Healthcare Ltd, ITH Pharma, LloydsPharmacy Clinical Homecare and 3 more
Contract starts 1 Apr 2024
What is being bought
Published requirement descriptionNHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)
Tender Reference: CM/PHR/22/5686/01
Period of framework agreement: 1 April 2024 to 31 March 2028 (covering regions East of England, London, North of England and South East).
Published procurement details
- Procedure
- Open procedure (above threshold)
- Buyer reference
- CF-2269700D0O000000rwimUAA
- Category
- Services
- Tender status
- Complete
- Award status
- Active
- Suitable for SMEs
- Yes
- Suitable for voluntary, community and social enterprises
- No
- Tender deadline
- Procurement method
- Open
- Item 1: Delivery locations as published
WA7 2ES; East of England, United Kingdom; London, United Kingdom; North East, United Kingdom; North West, United Kingdom; South East, United Kingdom; Yorkshire and the Humber, United Kingdom
Key dates
Published dates- Award decision11 Mar 2024
- Contract starts1 Apr 2024
- Notice published3 Apr 2024
- Contract ends31 Mar 2028
Contracting authority & participating public bodies
- NHS EnglandContracting authority
Suppliers named on the notice
- ITH PharmaSupplier
- Business size
- Large
- Qualasept Ltd t/a Bath ASUSupplier
- Business size
- Large
- Sciensus Pharma Services LimitedSupplier
- Business size
- Large
- Baxter Healthcare LtdSupplier
- Business size
- Large
- LloydsPharmacy Clinical HomecareSupplier
- Business size
- Large
- Quantum PharmaceuticalSupplier
- Business size
- SME
Official documents & specifications (6)
Official links; attachments are not copiedTender pack and attachments
- Parties Appointed to the Framework Agreement - CM-PHR-22-5686
- 2023S 000-031801 - FTS OPPORTUNITY NOTICE - CM-PHR-22-5686
- Document No. 09 - Participating Authorities - CM-PHR-22-5686
- Document No. 03 - Framework Agreement and Terms and Conditions - CM-PHR-22-5686
- CM-PHR-22-5686 Transparency Award Schedule (Redacted)
Notices published for this procedure
Source record
- Source
- Contracts Finder
- Notice language
- en
- Release reference
- ocds-b5fd17-5bdeb37b-fea5-437d-9dc4-a1415f3c6f1c-2024-04-03T11:54:35+01:00
- Published
- 3 Apr 2024
- Latest update
- 3 Apr 2024
- Procedure reference
- ocds-b5fd17-5bdeb37b-fea5-437d-9dc4-a1415f3c6f1c
- Contract reference
- ocds-b5fd17-5bdeb37b-fea5-437d-9dc4-a1415f3c6f1c-1